The high prevalence of APS and aPL positivity alongside other autoimmune conditions, notably SLE, has impeded the delineation of a distinct cognitive profile and the assessment of neuropsychiatric abnormalities in APS patients [60]. The gene discussed is FASLG; the disease is autoimmune polyendocrinopathy.